Carregant...

Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677

BACKGROUND: The prognosis for patients with recurrent glioblastoma remains poor. The purpose of this study was to assess the potential role of MR spectroscopy as an early indicator of response to anti-angiogenic therapy. METHODS: Thirteen patients with recurrent glioblastoma were enrolled in RTOG 06...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ratai, Eva-Maria, Zhang, Zheng, Snyder, Bradley S., Boxerman, Jerrold L., Safriel, Yair, McKinstry, Robert C., Bokstein, Felix, Gilbert, Mark R., Sorensen, A. Gregory, Barboriak, Daniel P.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2013
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3688017/
https://ncbi.nlm.nih.gov/pubmed/23645534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not044
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!